John S. Bradley

RGS5 expression is a quantitative measure of pericyte coverage of blood vessels

D. Shima, T. Mitchell, Y. Ng, 2007, Angiogenesis.

Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

David T. Shima, John Bradley, D. Shima, 2007, The American journal of pathology.

An in vitro assay reveals a role for the diaphragm protein PV-1 in endothelial fenestra morphogenesis

D. Shima, K. Deinhardt, Eunice Cheung, 2006, Proceedings of the National Academy of Sciences.

Combination therapy for the treatment of ocular neovascularization

G. Robinson, John Bradley, M. Ju, 2007, Angiogenesis.

Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization.

C. Mailhos, D. Shima, A. Adamis, 2006, The American journal of pathology.

In vitro Self-Assembly of Human Pericyte-Supported Endothelial Microvessels in Three-Dimensional Coculture: A Simple Model for Interrogating Endothelial-Pericyte Interactions

J. Pober, J. Bradley, J. Waters, 2013, Journal of Vascular Research.

Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.

John Bradley, D. Shima, A. Adamis, 2007, Investigative ophthalmology & visual science.

Simultaneous but not prior inhibition of VEGF165 enhances the efficacy of photodynamic therapy in multiple models of ocular neovascularization.

C. Mailhos, D. Shima, P. Calias, 2008, Investigative ophthalmology & visual science.